---
schema_version: "secwatch.filing_event.v1"
accession: "0001725160-23-000157"
form_type: "8-K"
ticker: "ZNTL"
cik: "0001725160"
company_name: "Zentalis Pharmaceuticals, Inc."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T22:44:53.997448+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Zentalis Pharmaceuticals furnishes August 2023 corporate presentation; no material new data disclosed

## Summary
- No earnings, guidance, or clinical data included in the 8-K filing.
- Corporate presentation dated August 2023; content not fully provided here.
- No changes to executive leadership, capital structure, or business strategy.

## SEC filing metadata
- accession: 0001725160-23-000157
- form_type: 8-K
- ticker: ZNTL
- cik: 0001725160
- company_name: Zentalis Pharmaceuticals, Inc.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725160/000172516023000157/0001725160-23-000157-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725160/000172516023000157/zntl-20230809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001725160-23-000157
- JSON: https://secwatch.observer/filing/0001725160-23-000157.json
- Plain text: https://secwatch.observer/filing/0001725160-23-000157.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.